[Skip to Navigation]
JAMA Network Home
Sign In

April 2023,Vol 159,No. 4,Pages364-463

Viewpoint

Dermatologic Care for Displaced Persons—Key Considerations and Approaches

Abstract Full Text
JAMA Dermatol. 2023;159(4):365-366. doi:10.1001/jamadermatol.2022.6375

This Viewpoint discusses actionable approaches in providing dermatologic care for displaced persons.

Incorporating Social Determinants of Health Into Medical Decision-making—Implications for Dermatology

Abstract Full Text
JAMA Dermatol. 2023;159(4):367-368. doi:10.1001/jamadermatol.2022.6475

This Viewpoint discusses incorporating social determinants of health into medical decision-making and its implications for dermatology.

Editorial

Characterizing Epidemiology and Burden of Disease in Alopecia Areata—Making It Count

Abstract Full Text
JAMA Dermatol. 2023;159(4):369-370. doi:10.1001/jamadermatol.2023.0001

Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes:Empowering Clinicians and Reducing Potential Harm

Abstract Full Text
has audio
JAMA Dermatol. 2023, 159(4): 371 - 373。doi: 10.1001 / jamadermatol.2022.6236
Original Investigation

Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis:Follow-up of the DESIRES Trial With a Focus on Serum Immunoglobulin Levels

Abstract Full Text
JAMA Dermatol. 2023;159(4):374-383. doi:10.1001/jamadermatol.2022.6340

This cohort study evaluates the long-term outcomes after rituximab treatment for systemic sclerosis and identifies potential response markers.

Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis:A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Dermatol. 2023;159(4):384-392. doi:10.1001/jamadermatol.2022.6378

This systematic review and meta-analysis of 38 studies including 2917 patients evaluates the prevalence of antibiotics associated with Stevens-Johnson syndrome and toxic epidermal necrolysis worldwide.

Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease

Abstract Full Text
JAMA Dermatol. 2023;159(4):393-402. doi:10.1001/jamadermatol.2022.6624

这个队列研究评估预后value of body surface area and National Institutes of Health Skin Score on survival outcomes stratified by erythema and sclerosis subtypes of chronic graft-vs-host disease.

Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis:A 2-Step Double-Blind Randomized Clinical Trial

Abstract Full Text
JAMA Dermatol. 2023;159(4):403-410. doi:10.1001/jamadermatol.2022.6687

This randomized clinical trial evaluates the efficacy and tolerance of methotrexate alone or combined with low-dose prednisone in patients with chronic and recalcitrant alopecia areata totalis or universalis.

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population

Abstract Full Text
open access
JAMA Dermatol. 2023;159(4):411-418. doi:10.1001/jamadermatol.2023.0002

This cohort study examines the annual prevalence and incidence of alopecia areata and alopecia totalis/alopecia universalis in the US.

Overall and Racial and Ethnic Subgroup Prevalences of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis

Abstract Full Text
JAMA Dermatol. 2023;159(4):419-423. doi:10.1001/jamadermatol.2023.0016

This cross-sectional study examines the prevalence of alopecia areata, alopecia totalis, and alopecia universalis overall and among racial and ethnic groups in the US.

Special Communication

Mpox—A Rapidly Evolving Disease

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(4):424-431. doi:10.1001/jamadermatol.2023.0041

This Special Communication provides an overview of the evolution of mpox skin findings from its initial description in humans in 1970 to the present-day multinational outbreak.

Review

Strategies to Improve Adherence to Skin Self-examination and Other Self-management Practices in People at High Risk of Melanoma:A Scoping Review of Randomized Clinical Trials

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(4):432-440. doi:10.1001/jamadermatol.2022.6478

This scoping review describes strategies to improve adherence to self-management practices in randomized clinical trials of people at high risk of melanoma.

Consensus Statement

Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(4):441-447. doi:10.1001/jamadermatol.2022.6266

This consensus agreement study creates a set of standard definitions for hidradenitis suppurativa surgical procedures using a 2-round modified Delphi consensus method, including 50 international experts in the first round and 33 in the second.

Images in Dermatology

Linear and Annular Lupus Panniculitis of the Scalp

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(4):448. doi:10.1001/jamadermatol.2022.5631

This case report describes hair loss in a linear pattern toward the frontal scalp, with associated erythema on left forehead.

Eruptive Xanthomas

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(4):449. doi:10.1001/jamadermatol.2022.5834

This case report describes numerous dome-shaped, firm, yellow papules that were present symmetrically on the back, shoulder, arm, thigh, and knees.

JAMA Dermatology Clinicopathological Challenge

Numerous Ulcerated Plaques of the Trunk and Extremities in a Patient Receiving Long-term Hydroxyurea Therapy

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(4):450-451. doi:10.1001/jamadermatol.2022.6602

A woman in her 80s initially presented with numerous, primarily photodistributed, crusted, and ulcerated plaques of the trunk and extremities and a medical history of essential thrombocytosis treated with hydroxyurea for 14 years. What is your diagnosis?

Long History of Multiple Painless Scalp Nodules in a Middle-aged Woman

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(4):452-453. doi:10.1001/jamadermatol.2023.0024

A woman in her late 40s presented with a 40-year history of hard nodules on the scalp, feet, trunk, and lower extremities. What is your diagnosis?

Research Letter

Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018

Abstract Full Text
JAMA Dermatol. 2023;159(4):454-456. doi:10.1001/jamadermatol.2022.6647

This cross-sectional study of National Health Interview Survey data examines differences among sociodemographic subgroups in reported incidence of eczema in children in the US.

Patient Perspectives on Clinic Note Transparency Within Dermatology

Abstract Full Text
JAMA Dermatol. 2023;159(4):456-458. doi:10.1001/jamadermatol.2023.0086

This survey study assesses dermatology patient experiences with viewing online medical records and seeks to identify areas for improvement.

Observation

Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin

Abstract Full Text
JAMA Dermatol. 2023;159(4):458-460. doi:10.1001/jamadermatol.2022.6591

This case report describes 2 patients withPtychotropicporokeratosis who were treated with a combination of cholesterol and simvastatin.

Vascular-Targeted Therapy for Systemic Lupus Erythematosus–Associated Vasculitis

Abstract Full Text
JAMA Dermatol. 2023;159(4):460-462. doi:10.1001/jamadermatol.2023.0077

This case report describes a woman in her 40s with a medical history of systemic lupus erythematosus with 1 year of tender papules, plaques, and progressive ulcers on her hands and feet.

Comment & Response

Shared Decision-making, Therapeutic Choice, and Decisional Regret in Alopecia Areata—Where Narrative Ethics Meets the Unconscious Bias of Clinicians

Abstract Full Text
JAMA Dermatol. 2023;159(4):462. doi:10.1001/jamadermatol.2022.6534

Shared Decision-making, Therapeutic Choice and Decisional Regret in Alopecia Areata—Where Narrative Ethics Meets the Unconscious Bias of Clinicians—Reply

Abstract Full Text
JAMA Dermatol. 2023;159(4):462-463. doi:10.1001/jamadermatol.2022.6533
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2023;159(4):364. doi:10.1001/jamadermatol.2022.4408
×
Baidu
map